BenzamidesLeukemia, Myeloid, Chronic-PhaseAmyloidosisLeukemia, Myeloid, Accelerated PhaseLeukemia, Myelogenous, Chronic, BCR-ABL PositivePiperazinesPyrimidinesCytogenetic AnalysisBlast CrisisBlood Cell CountHarringtoninesFusion Proteins, bcr-ablImmunoglobulin Light ChainsHematologic TestsTreatment OutcomeAnemia, AplasticInterferon-alphaThalidomideRemission InductionAntineoplastic AgentsMyelodysplastic SyndromesPhiladelphia ChromosomeHematocritHemoglobinsThiazolesDexamethasoneMelphalanProtein Kinase InhibitorsAnemiaSurvival RateDrug Administration ScheduleSurvival AnalysisDrug Resistance, NeoplasmFollow-Up StudiesErythropoietinCytarabineDose-Response Relationship, DrugImmunosuppressive AgentsAdministration, OralRecombinant ProteinsPrognosisAntineoplastic Combined Chemotherapy ProtocolsDisease-Free SurvivalTime FactorsRetrospective Studies